Skip to main content

Table 1 Patient characteristics

From: Sodium glucose co-transporter-2 inhibitors in intensive care unit patients with type 2 diabetes: a pilot case control study

Characteristic

Control group (n = 72)

Treatment group (n = 18)

P value

Age, years

66 (59–73)

60 (53–69)

0.15

HbA1c, %

7.7 (6.5–8.5)

7.7 (7.2–9.6)

0.38

ICU length of stay, days

6 (3–10)

8 (4–16)

0.14

Male sex

47/72 (65%)

14/18 (78%)

0.31

Body weight, kga

87 (72–108)

94 (83–102)

0.31

Comorbidity

 Cardiovascular disease

7/72 (10%)

11/18 (61%)

 < 0.001

 Renal disease

0/72 (0%)

4/18 (22%)

 < 0.001

 Lung disease

9/72 (12%)

6/18 (33%)

0.034

 Liver disease

9/72 (12%)

2/18 (11%)

0.87

Baseline creatinine, µmol/l

81 (62–142)

98 (88–101)

0.88

Diabetes therapy

0.93

 Insulin only

12/72 (17%)

4/18 (22%)

 

 Insulin & noninsulin glucose-lowering drugs

17/72 (24%)

4/18 (22%)

 

 Noninsulin glucose-lowering drugs only

32/72 (44%)

8/18 (44%)

 

 Diet control only

11/72 (15%)

2/18 (11%)

 

Location before ICU

 < 0.001

 Operating room

44/71 (62%)

4/18 (22%)

 

 Emergency department

5/71 (7%)

8/18 (44%)

 

 Ward

17/71 (24%)

5/18 (28%)

 

 Other hospital

5/71 (7%)

1/18 (6%)

 

Admission diagnosisb

 Sepsis

4/72 (6%)

10/18 (56%)

 < 0.001

 Cardiovascular

37/72 (51%)

3/18 (17%)

0.008

 Neurological

6/72 (8%)

2/18 (11%)

0.71

 Gastrointestinal

14/72 (19%)

0/18 (0%)

0.042

 Respiratory

7/72 (10%)

4/18 (22%)

0.15

 Trauma

1/72 (1%)

1/18 (6%)

0.28

 Renal

43/72 (60%)

0/18 (0%)

 < 0.001

 Hematological

2/72 (3%)

0/18 (0%)

0.47

Mechanical ventilation

53/72 (74%)

15/18 (83%)

0.39

Renal replacement therapy

3/72 (4%)

1/18 (6%)

0.80

Vasopressor infusion

29/72 (40%)

12/18 (67%)

0.044

APACHE III score

60 (42–77)

62 (46–71)

0.94

  1. Data are presented as median (IQR) for continuous measures, and n/total number with data (%) for categorical measures
  2. HbA1c glycated hemoglobin A1c, ICU intensive care unit, APACHE acute physiology and chronic health evaluation
  3. aData was missing in 5 patients in the control group
  4. bPatients can have more than one admission diagnosis